MBRX Earnings

Quarterly EPS
$-47.25
Q3 2024
$-9.32
Q4 2024
$-15.80
Q1 2025
$-28.68
Q2 2025
$-17.00
Q3 2025
$0.00
Q4 2025
$-3.54
Q1 2026
$-1.40
Q2 2026
Latest RevenueN/A
Latest Net Income-7635000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.400-7635000+95.1%
Q1 2026-$3.540-12845000+77.6%
Q4 2025015.4M
Q3 2025-$17.000-25399000+64.0%
Q2 2025-$28.680-17809000+32.5%
Q1 2025-$15.800-5904000+68.7%
Q4 2024-$9.320-6584000+92.7%
Q3 2024-$47.250-7024000+33.0%
Q2 2024-$42.500-4319000
Q1 2024-$50.500-4970000
Q4 2023-$127.140-10269000
Q3 2023-$70.500-5609000
Moleculin Biotech (MBRX) — Earnings